Official communication about our medicines
containing semaglutide from Novo Nordisk
This site is intended for a US audience
ILLEGAL MASS COMPOUNDING
Mass compounding GLP-1s is not proven to be safe or effective at any price. Read more about what Novo Nordisk is doing to protect patients from unproven, potentially unsafe knockoffs.
Chronic Weight Management
Wegovy® (semaglutide) tablets are a prescription medicine used with a reduced-calorie diet and increased physical activity to:
- reduce the risk of major cardiovascular events such as death, heart attack, or stroke in adults with known heart disease and with either obesity or overweight
- help adults with obesity, or some adults with excess weight (overweight) who also have weight-related medical problems to lose weight and keep the weight off
Wegovy® (semaglutide) injection is a prescription medicine used with a reduced-calorie diet and increased physical activity to:
- reduce the risk of major cardiovascular events such as death, heart attack, or stroke in adults with known heart disease and with either obesity or overweight
- help adults and children aged 12 years and older with obesity, or some adults with excess weight (overweight) who also have weight-related medical problems to lose weight and keep the weight off
Type 2 Diabetes
Ozempic® is an FDA-approved prescription medicine used:
- along with diet and exercise to improve blood sugar (glucose) in adults with type 2 diabetes
- to reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes with known heart disease
- to reduce the risk of worsening kidney disease, kidney failure (end-stage kidney disease), and death due to cardiovascular disease in adults who also have chronic kidney disease
RYBELSUS® (semaglutide) is an FDA-approved prescription medicine used:
- along with diet and exercise to improve blood sugar (glucose) in adults with type 2 diabetes
- to reduce the risk of major cardiovascular events such as heart attack, stroke or death in adults with type 2 diabetes mellitus who are at high risk for these events
